Evidence map›Paper›PMID 33390818›Full record

ArticleInternational journal of medical sciences2021

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.

Mei-Xiang Li, Meng-Yu Zhang, Huan-Huan Dong, Ai-Jun Li, Hai-Feng Teng, Ai-Ling Liu, Ning Xu, Yi-Qing Qu

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mei-Xiang LiDepartment of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Meng-Yu ZhangDepartment of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Huan-Huan DongDepartment of Pathology, Weihai Municipal Hospital, Weihai 264200, China.
Ai-Jun LiDepartment of Respiratory Medicine, Weihai Municipal Hospital, Weihai 264200, China.
Hai-Feng TengDepartment of Respiratory Medicine, Weihai Municipal Hospital, Weihai 264200, China.
Ai-Ling LiuDepartment of Respiratory Medicine, Weihai Municipal Hospital, Weihai 264200, China.
Ning XuDepartment of Respiratory Medicine, Weihai Municipal Hospital, Weihai 264200, China.
Yi-Qing QuDepartment of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Qilu Hospital of Shandong University · CNWeihai Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenocarcinoma of LungAnimalsBiomarkers, TumorCell Line, TumorCell ProliferationChromosomal Proteins, Non-HistoneDatasets as TopicDisease-Free SurvivalDisease ProgressionFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLungLung NeoplasmsMiceBiomarkers, Tumorcentromere protein FChromosomal Proteins, Non-HistoneMicrofilament Proteinscell cycleCENPFLUADprognostic biomarker

Identifiers

PMID33390818
PMCPMC7757141
OpenAlexW3112540073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.